Palisade Bio
PALI
8 hedge funds and large institutions have $298K invested in Palisade Bio in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 9 closing their positions.
6.31% more ownership
Funds ownership: 0.69% → 7% (+6.3%)
23% less capital invested
Capital invested by funds: $385K → $298K (-$87K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
47% less funds holding
Funds holding: 15 → 8 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Marex Group
London,
|
+$182K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.84K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.03K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$27 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$110K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.7K |
| 4 |
HF
HRT Financial
New York
|
-$12K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$11.3K |
PALI Hedge Fund Activity: Q2 2024 in Review
8 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2024, worth a combined $298K — down 23% from $385K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PALI and 2 opened new positions — a net loss of 7 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Marex Group, adding an estimated $182K. The largest seller was Armistice Capital, cutting an estimated $110K.
- 8 institutional investors held Palisade Bio (PALI) as of Q2 2024, down from 15 in Q1 2024.
- Funds reported $298K of Palisade Bio stock for Q2 2024, down 23% quarter-over-quarter.
- 2 funds opened new Palisade Bio positions in Q2 2024 and 9 closed out, a net change of -7 holders.
- The largest Palisade Bio buyer in Q2 2024 was Marex Group, an estimated $182K added.
- The largest Palisade Bio seller in Q2 2024 was Armistice Capital, an estimated $110K sold.
Based on aggregated 13F filings for Q2 2024.